Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H6ClNO |
| Molecular Weight | 179.603 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C2N=CC=CC2=C(Cl)C=C1
InChI
InChIKey=CTQMJYWDVABFRZ-UHFFFAOYSA-N
InChI=1S/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H
| Molecular Formula | C9H6ClNO |
| Molecular Weight | 179.603 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://aac.asm.org/content/51/3/1105.full.pdfCurator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/24513205
Sources: http://aac.asm.org/content/51/3/1105.full.pdf
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/24513205
Cloxyquin has being shown to be a novel activator of the two-pore domain
potassium channel TRESK, which is linked to causing migraines and controls the sensitivity of pain nerves in the brain.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: UNIPROT: Q208C2 (Acyl-CoA-binding protein) Sources: http://www.ncbi.nlm.nih.gov/pubmed/22167242 |
0.097 µM [IC50] | ||
Target ID: CHEMBL360 Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803129/ |
|||
Target ID: CHEMBL2331042 Sources: http://www.ncbi.nlm.nih.gov/pubmed/24513205 |
3.8 µM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction. | 2013-03-28 |
|
| Grafting aluminum(III) 8-hydroxyquinoline derivatives on MCM-41 mesoporous silica for tuning of the light emitting color. | 2010-06-15 |
|
| 5-Chloro-8-hydroxy-quinolinium nitrate. | 2009-05-29 |
|
| Bis(μ-5-chloro-quinolin-8-olato)-κN,O:O;κO:N,O-bis-[(acetato-κO,O')lead(II)]. | 2009-02-11 |
|
| Outlook on Thailand's genomics and computational biology research and development. | 2008-07-25 |
|
| Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. | 2007-11-01 |
|
| In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. | 2007-03 |
|
| The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. | 2006-03-15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=17178795
Curator's Comment: Growth of the organisms was determined after reincubation at 37°C for 16 to 24 h by visual determination of a color change from blue to pink. The MIC was defined as the lowest concentration which prevented the color change.
The MICs of cloxyquin for 150 clinical isolates of Mycobacterium tuberculosis ranged from 0.062 to 0.25 g/ml. The MIC50 and MIC90 were 0.125 and 0.25 g/ml, respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:51:49 GMT 2025
by
admin
on
Mon Mar 31 17:51:49 GMT 2025
|
| Record UNII |
BPF36H1G6S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C254
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID4045973
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
BPF36H1G6S
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
204-978-1
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
C61689
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL225164
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
100000084038
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
3428
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
130-16-5
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
SUB06784MIG
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
3114
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
2817
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | |||
|
m3675
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
35083
Created by
admin on Mon Mar 31 17:51:49 GMT 2025 , Edited by admin on Mon Mar 31 17:51:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |